Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

Motoko Yanagita; Satoru Muto; Hiroyuki Nishiyama; Yuichi Ando; Sumio Hirata; Kent Doi; Yutaka Fujiwara; Norio Hanafusa; Takahiro Hatta; Junichi Hoshino; Satoko Ichioka; Takamitsu Inoue; Kenji Ishikura; Taigo Kato; Hiroshi Kitamura; Yusuke Kobayashi; Yuichi Koizumi; Chihiro Kondoh; Takeshi Matsubara; Kazuo Matsubara; Koji Matsumoto; Yusuke Okuda; Yuta Okumura; Emiko Sakaida; Yugo Shibagaki; Hideki Shimodaira; Nao Takano; Akiko Uchida; Kimikazu Yakushijin; Takehito Yamamoto; Kazuhiro Yamamoto; Yoshinari Yasuda; Mototsugu Oya; Hirokazu Okada; Masaomi Nangaku; Naoki Kashihara

doi:10.1007/s10157-023-02415-0

Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

Motoko Yanagita^*, Satoru Muto, Hiroyuki Nishiyama, Yuichi Ando, Sumio Hirata, Kent Doi, Yutaka Fujiwara, Norio Hanafusa, Takahiro Hatta, Junichi Hoshino, Satoko Ichioka, Takamitsu Inoue, Kenji Ishikura, Taigo Kato, Hiroshi Kitamura, Yusuke Kobayashi, Yuichi Koizumi, Chihiro Kondoh, Takeshi Matsubara, Kazuo MatsubaraKoji Matsumoto, Yusuke Okuda, Yuta Okumura, Emiko Sakaida, Yugo Shibagaki, Hideki Shimodaira, Nao Takano, Akiko Uchida, Kimikazu Yakushijin, Takehito Yamamoto, Kazuhiro Yamamoto, Yoshinari Yasuda, Mototsugu Oya, Hirokazu Okada, Masaomi Nangaku, Naoki Kashihara

^*Corresponding author for this work

Urology

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	85-122
Number of pages	38
Journal	Clinical and Experimental Nephrology
Volume	28
Issue number	2
DOIs	https://doi.org/10.1007/s10157-023-02415-0
State	Published - 2024/02

Keywords

Acute kidney injury
Anticancer drug therapy
Cancer survivors
Glomerular filtration rate
Immune checkpoint inhibitors

ASJC Scopus subject areas

Physiology
Nephrology
Physiology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10157-023-02415-0

Cite this

Yanagita, M., Muto, S., Nishiyama, H., Ando, Y., Hirata, S., Doi, K., Fujiwara, Y., Hanafusa, N., Hatta, T., Hoshino, J., Ichioka, S., Inoue, T., Ishikura, K., Kato, T., Kitamura, H., Kobayashi, Y., Koizumi, Y., Kondoh, C., Matsubara, T., ... Kashihara, N. (2024). Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022. Clinical and Experimental Nephrology, 28(2), 85-122. https://doi.org/10.1007/s10157-023-02415-0

@article{754d209cebdc479883672fc2e232d30d,

title = "Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022",

keywords = "Acute kidney injury, Anticancer drug therapy, Cancer survivors, Glomerular filtration rate, Immune checkpoint inhibitors",

author = "Motoko Yanagita and Satoru Muto and Hiroyuki Nishiyama and Yuichi Ando and Sumio Hirata and Kent Doi and Yutaka Fujiwara and Norio Hanafusa and Takahiro Hatta and Junichi Hoshino and Satoko Ichioka and Takamitsu Inoue and Kenji Ishikura and Taigo Kato and Hiroshi Kitamura and Yusuke Kobayashi and Yuichi Koizumi and Chihiro Kondoh and Takeshi Matsubara and Kazuo Matsubara and Koji Matsumoto and Yusuke Okuda and Yuta Okumura and Emiko Sakaida and Yugo Shibagaki and Hideki Shimodaira and Nao Takano and Akiko Uchida and Kimikazu Yakushijin and Takehito Yamamoto and Kazuhiro Yamamoto and Yoshinari Yasuda and Mototsugu Oya and Hirokazu Okada and Masaomi Nangaku and Naoki Kashihara",

year = "2024",

month = feb,

doi = "10.1007/s10157-023-02415-0",

language = "英語",

volume = "28",

pages = "85--122",

journal = "Clinical and Experimental Nephrology",

issn = "1342-1751",

publisher = "Springer",

number = "2",

}

Yanagita, M, Muto, S, Nishiyama, H, Ando, Y, Hirata, S, Doi, K, Fujiwara, Y, Hanafusa, N, Hatta, T, Hoshino, J, Ichioka, S, Inoue, T, Ishikura, K, Kato, T, Kitamura, H, Kobayashi, Y, Koizumi, Y, Kondoh, C, Matsubara, T, Matsubara, K, Matsumoto, K, Okuda, Y, Okumura, Y, Sakaida, E, Shibagaki, Y, Shimodaira, H, Takano, N, Uchida, A, Yakushijin, K, Yamamoto, T, Yamamoto, K, Yasuda, Y, Oya, M, Okada, H, Nangaku, M & Kashihara, N 2024, 'Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022', Clinical and Experimental Nephrology, vol. 28, no. 2, pp. 85-122. https://doi.org/10.1007/s10157-023-02415-0

TY - JOUR

T1 - Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022

AU - Yanagita, Motoko

AU - Muto, Satoru

AU - Nishiyama, Hiroyuki

AU - Ando, Yuichi

AU - Hirata, Sumio

AU - Doi, Kent

AU - Fujiwara, Yutaka

AU - Hanafusa, Norio

AU - Hatta, Takahiro

AU - Hoshino, Junichi

AU - Ichioka, Satoko

AU - Inoue, Takamitsu

AU - Ishikura, Kenji

AU - Kato, Taigo

AU - Kitamura, Hiroshi

AU - Kobayashi, Yusuke

AU - Koizumi, Yuichi

AU - Kondoh, Chihiro

AU - Matsubara, Takeshi

AU - Matsubara, Kazuo

AU - Matsumoto, Koji

AU - Okuda, Yusuke

AU - Okumura, Yuta

AU - Sakaida, Emiko

AU - Shibagaki, Yugo

AU - Shimodaira, Hideki

AU - Takano, Nao

AU - Uchida, Akiko

AU - Yakushijin, Kimikazu

AU - Yamamoto, Takehito

AU - Yamamoto, Kazuhiro

AU - Yasuda, Yoshinari

AU - Oya, Mototsugu

AU - Okada, Hirokazu

AU - Nangaku, Masaomi

AU - Kashihara, Naoki

PY - 2024/2

Y1 - 2024/2

KW - Acute kidney injury

KW - Anticancer drug therapy

KW - Cancer survivors

KW - Glomerular filtration rate

KW - Immune checkpoint inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85164946876&partnerID=8YFLogxK

U2 - 10.1007/s10157-023-02415-0

DO - 10.1007/s10157-023-02415-0

M3 - 学術論文

C2 - 37878114

AN - SCOPUS:85164946876

SN - 1342-1751

VL - 28

SP - 85

EP - 122

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

IS - 2

ER -